secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUTRO BIOPHARMA, INC. (STRO)
CIK:        0001382101
Form:       8-K
Filed at:   2021-11-17T23:59:59+00:00
Accession:  0001564590-21-057374
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sutro Biopharma appoints Heidi Hunter as Class I director, effective Nov 19, 2021
--------------------------------------------------------------------------------

- Heidi Hunter appointed Class I director and member of Audit and Science & Technology Committees.
- Receives pro rata annual retainers: $40K director, $10K audit, $5K science/tech.
- Granted option for 24,000 shares vesting monthly over three years; 9,884 shares vesting until 2022 annual meeting.
- Exercise price equals closing price on Nov 19, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382101/000156459021057374/0001564590-21-057374-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382101/000156459021057374/stro-8k_20211112.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-057374

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer